References
1. Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis
JPA, et al. Biomedical research: increasing value, reducing waste.
Lancet. 2014;383(9912):101-4.
2. Hackbarth AD. Eliminating Waste in US Health Care. JAMA. 2012 Apr
11;307(14):1513.
3. Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG. CONSORT 2010
statement: extension checklist for reporting within person randomised
trials. BMJ. 2017 Jun 30;j2835.
4. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et
al. RoB 2: a revised tool for assessing risk of bias in randomised
trials. BMJ. 2019;366:14898.
5. Ioannidis JPA. Why Most Clinical Research Is Not Useful. PLOS Med.
2016 Jun 21;13(6):e1002049.
6. Blencove H, Cousens S, Oesergaard M, Chou D, Moller AB, Narewal R, et
al. National, regional and worldwide estimates of preterm birth. Lancet.
2012;379(9832):2162-72.
7. Aarnoudse-Moens CSH, Weisglas-Kuperus N, van Goudoever JB, Oosterlaan
J. Meta-Analysis of Neurobehavioral Outcomes in Very Preterm and/or Very
Low Birth Weight Children. PEDIATRICS. 2009 Aug 1;124(2):717–28.
8. Medley N, Vogel JP, Care A, Alfirevic Z. Interventions during
pregnancy to prevent preterm birth: an overview of Cochrane systematic
reviews. Cochrane Pregnancy and Childbirth Group, editor. Cochrane
Database Syst Rev [Internet]. 2018 Nov 14 [cited 2020 Aug 27];
Available from: http://doi.wiley.com/10.1002/14651858.CD012505.pub2
9. Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal
administration of progesterone for preventing preterm birth in women
considered to be at risk of preterm birth. Cochrane Pregnancy and
Childbirth Group, editor. Cochrane Database Syst Rev [Internet].
2013 Jul 31 [cited 2020 Sep 2]; Available from:
http://doi.wiley.com/10.1002/14651858.CD004947.pub3
10. the EPPPIC group. Evaluating Progestogens for Preventing Preterm
birth International Collaborative (EPPPIC): meta-analysis of individual
participant data from randomised controlled trials. Lancet.
2021;397(10280).
11. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman
DG, et al. A pragmatic–explanatory continuum indicator summary
(PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009
May;62(5):464–75.
12. Dal-Ré R, Janiaud P, Ioannidis JPA. Real-world evidence: How
pragmatic are randomized controlled trials labeled as pragmatic? BMC
Med. 2018 Dec;16(1):49.
13. Meltzer DO, Hoomans T, Chung JW, Basu A. Minimal modeling approaches
to value of information analysis for health research. Med Decis Making.
2011;31(6):E1-E22.
14. Mauskopf JA, Earnshaw S, Mullins CD. Budget impact analysis: review
of the state of the art. Expert Rev Pharmacoecon Outcomes Res. 2005
Feb;5(1):65–79.
15. Djamel D. Latest Impact Factors Journal List, Thomson Reuters based
on 2019 Journal Citation Reports. 2019 [cited 2020 Aug 27];
Available from: http://rgdoi.net/10.13140/RG.2.2.15078.06720
16. Evangelou E, Siontis KC, Pfeiffer T, Ioannidis JPA. Perceived
information gain from randomized trials correlates with publication in
high–impact factor journals. J Clin Epidemiol. 2012
Dec;65(12):1274–81.
17. Clarke M, Hopewell S, Chalmers I. Reports of clinical trials should
begin and end with up-to-date systematic reviews of other relevant
evidence: a status report. 2007;100:4.
18. Heneghan C, Aronson JK. Why reports of clinical trials should
include updated meta-analyses. BMJ Evid-Based Med. 2020 Feb;25(1):1–2.
19. Copsey B, Thompson JY, Vadher K, Ali U, Dutton SJ, Fitzpatrick R, et
al. Sample size calculations are poorly conducted and reported in many
randomized trials of hip and knee osteoarthritis: results of a
systematic review. J Clin Epidemiol. 2018 Dec;104:52–61.
20. Iqbal SA, Wallach JD, Khoury MJ, Schully SD, Ioannidis JPA.
Reproducible Research Practices and Transparency across the Biomedical
Literature. Vaux DL, editor. PLOS Biol. 2016 Jan 4;14(1):e1002333.
21. Wallach JD, Boyack KW, Ioannidis JPA. Reproducible research
practices, transparency, and open access data in the biomedical
literature, 2015–2017. Dirnagl U, editor. PLOS Biol. 2018 Nov
20;16(11):e2006930.
22. Townsend R, Duffy JMN, Khalil A. Increasing value and reducing
research waste in obstetrics: towards woman‐centered research.
Ultrasound Obstet Gynecol. 2020 Feb;55(2):151–6.
23. Prior M, Hibberd R, Asemota N, Thornton J. Inadvertent P-hacking
among trials and systematic reviews of the effect of progestogens in
pregnancy? A systematic review and meta-analysis. BJOG Int J Obstet
Gynaecol. 2017 Jun;124(7):1008–15.
24. Uhm S, Crowe S, Dowling I, Oliver S. The process and outcomes of
setting research priorities about preterm birth – a collaborative
partnership. Infant. 2014;10(6):178–81.
25. van ‘t Hooft J, Alfirevic Z, Asztalos E, Biggio J, Dugoff L, Hoffman
M, et al. CROWN initiative and preterm birth prevention: researchers and
editors commit to implement core outcome sets. BJOG Int J Obstet
Gynaecol. 2018 Jan;125(1):8–11.
26. Yudkin JS, Lipska KJ, Montori VM. The idolatry of the surrogate.
BMJ. 2011 Dec 28;343(dec28 1):d7995–d7995.
27. Ross S, Milne J, Dwinnell S, Tang S, Wood S. Is it possible to
estimate the minimal clinically important treatment effect needed to
change practice in preterm birth prevention? Results of an obstetrician
survey used to support the design of a trial. BMC Med Res Methodol. 2012
Dec;12(1):31.
28. Tunis SR, Stryer DB, Clancy CM. Practical Clinical Trials:
Increasing the Value of Clinical Research for Decision Making in
Clinical and Health Policy. JAMA [Internet]. 2003 Sep 24 [cited
2020 Aug 27];290(12). Available from:
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.290.12.1624